Empowering global wellness brands, Amazon storefronts, and healthcare organizations with audit-ready Private Label Dietary Supplement Manufacturing. Built on 30+ years of CDMO authority, 21 CFR 111 cGMP standards, and a 90-day launch pipeline across six core dosage platforms.
Full batch records & ISO 17025 accredited Certificate of Analysis (COA)
Amazon Dietary Supplement Compliance & Regulatory Dossier Support
30 years of global contract development & manufacturing heritage
Navigating the modern health supplement supply chain demands more than simple copacking. PAG Pharmatech America functions as a fully integrated Contract Development and Manufacturing Organization (CDMO), providing high-yield formulation, strict batch reproducibility, and multi-jurisdictional compliance.
Engineered under strict Federal Dietary Supplement cGMP guidelines in Springville, Utah. Our environmental controls, raw material identity testing (FTIR/HPLC), and sanitation protocols ensure 100% audit readiness for FDA inspections and retail buyer vetting.
From initial benchtop formulation to full-scale automated packaging, our integrated timeline mitigates lead-time inflation. Private label catalog SKUs ship in 8–10 weeks; complex custom R&D formulas complete in 12–16 weeks with accelerated stability data.
We eliminate inventory locking by offering optimized minimum order thresholds: 6,000 units for gummies, 5,000 units for capsules, softgels, and tablets, or 300 kg for nutraceutical powders. Scale effortlessly into multi-pallet commercial production runs.
Headquartered in Utah for North American supply chain resilience, with an EU-GMP plant in the Netherlands for European market registration and a Shenzhen site for global raw material procurement—enabling seamless international expansion.
Procurement teams frequently encounter severe delays when transitioning from concept to commercial sales due to non-compliant documentation. Modern marketplaces like Amazon require strict compliance with ISO/IEC 17025 accredited Certificate of Analysis (COA) testing. PAG Pharmatech’s quality release protocol automatically integrates potency assays, heavy metals testing (Lead, Arsenic, Cadmium, Mercury via ICP-MS), microbial screening (E. coli, Salmonella, Total Aerobic Plate Count), and residual solvent checks into every master batch record—ensuring zero product holds.
Select the optimal delivery matrix for your active ingredients. Every format is manufactured within our climate-controlled Utah cleanrooms using state-of-the-art automated encapsulation, tableting, and depositing technology.
High-potency starchless mold gummy production. Sugar-free maltitol/erythritol or organic tapioca bases with precision active dosing (vitamins, botanical extracts, functional mushrooms).
Gummy CDMO Specs →
Homogeneous V-blending and high-speed auger filling for pre-workout energy, whey/plant protein, collagen peptides, and hydration electrolyte sachets.
Powder CDMO Specs →
Direct compression and wet granulation for chewable, sublingual, film-coated, multi-layer, and effervescent tablets engineered for controlled dissolution.
Tablet CDMO Specs →
Nitrogen-flushed rotary die encapsulation for lipid-soluble compounds, high-concentrate EPA/DHA Omega-3 oils, CoQ10 suspension, and Vitamin D3/K2 formulations.
Softgel CDMO Specs →
Size 000 to 0 encapsulated powders, beaded formulas, and liquid-filled hard capsules using Non-GMO HPMC (vegetarian) or Bovine Gelatin shells with zero excipient options.
Capsule CDMO Specs →
Cold-extrusion soft chews and palatability-tested powder toppers for canine and feline joint health, calming blends, and gut biome support complying with AAFCO guidelines.
Pet CDMO Specs →Choosing between off-the-shelf private label formulas and custom R&D affects speed-to-market, unit economics, and intellectual property ownership. The matrix below provides procurement directors with transparent benchmarks to guide strategic sourcing decisions:
| Operational Criteria | Turnkey Private Label Manufacturing | Custom Formulation CDMO R&D |
|---|---|---|
| Target Lead Time | 8 – 10 Weeks (Rapid Deployment) | 12 – 16 Weeks (Includes R&D & Stability) |
| Formula Customization | Pre-validated base formulas with custom packaging | 100% proprietary ingredient profiles & dosages |
| Minimum Order Quantity (MOQ) | 5,000 Bottles / Units (300 kg Powders) | 10,000+ Units (Optimized for Scale) |
| R&D & Pilot Batch Fee | $0 (Included in Turnkey Catalog) | Fully rebated upon commercial volume run |
| Regulatory & Testing Dossier | Immediate cGMP COA & Specification Sheet | Full Method Validation, Assay & Stability Records |
| Amazon & Retail Audit Fit | Instant compliance for quick marketplace launch | Tailored for differentiated patent/claim strategies |
Omnichannel Compliance for Multi-Platform Supplement Brands
The dietary supplement market is undergoing a structural evolution driven by heightened regulatory scrutiny, consumer demand for clean labels, and breakthroughs in ingredient bioavailability. Brand owners must align with CDMOs capable of navigating these shifts.
Standard crude botanical powders are rapidly giving way to lipid-shielded liposomal powders, micro-encapsulated actives, and targeted enteric delivery capsules. These technologies protect heat-sensitive and acid-labile nutrients (such as NAD+ precursors, glutathione, and live probiotics) through the digestive tract, allowing brands to make legitimate high-potency structure-function claims backed by pharmacokinetic data.
Consumers actively avoid magnesium stearate, silicon dioxide, titanium dioxide, and artificial food colorings. The market demands natural flow agents like organic rice hulls, tapioca starch, and natural fruit/vegetable color concentrates. PAG Pharmatech has perfected non-synthetic capsule filling and pectin gummy matrix stability without sacrificing machine throughput or shelf life.
As functional gummies and instantized beverage powders capture market share, masking bitter botanical actives (e.g., Ashwagandha, BCAAs, marine collagen) is crucial for customer retention. We leverage micro-encapsulation and advanced natural flavor-pairing algorithms to maximize organoleptic appeal without artificial sweeteners or sugar overloads.
Global regulators and online marketplaces (Amazon, Walmart, TikTok Shop) have eliminated informal self-testing policies. Brands must supply rigorous analytical proof of identity, purity, heavy metals, and potency from ISO 17025 accredited labs. Partnering with an FDA-registered, cGMP 21 CFR 111 facility ensures your catalog remains protected against sudden delistings or recall notices.
Relying on a single domestic or overseas manufacturer exposes brands to geopolitical tariffs, freight price spikes, and batch delivery failures. PAG Pharmatech’s Global Integrated System allows clients to formulate once under uniform standard operating procedures (SOPs) and produce flexibly across our Utah, Netherlands, and Shenzhen plants—securing optimal unit costs while safeguarding product supply.
Eliminate project hand-off delays. Our Utah facility executes a disciplined four-stage manufacturing protocol managed by dedicated technical account directors, ensuring seamless speed-to-market.
Our in-house chemists evaluate active compatibility, dosage volume, taste profile, and label claim feasibility—delivering physical lab prototypes within 14 business days.
Every active and excipient undergoes 100% identity verification (FTIR), heavy metal analysis (ICP-MS), and microbiological screening before release into production.
High-speed encapsulation, tablet compression, or gummy depositing with strict in-process weight variation, hardness, friability, and moisture testing every 30 minutes.
Final finished-goods testing against master specifications. We release full batch production records alongside an accredited COA, shipping directly to your fulfillment centers.
Tour our climate-monitored manufacturing plant in Springville, Utah. We operate positive-pressure cleanrooms, automated encapsulation lines, and an on-site analytical quality control laboratory.
Positive-Pressure Cleanroom Suites
Automated Packaging Lines
Climate-Controlled Logistics
Analytical QC Laboratory
High-Speed EncapsulationIntegrated Dosage Platforms Operating Under cGMP 21 CFR Part 111 & Part 117 Standards.
Inquire Now - Schedule Facility AuditScale your brand internationally without re-qualifying vendors. PAG’s Global Integrated System delivers unified quality specifications across North America, Europe, and Asia.
FDA-registered, cGMP, SQF Edition 9 facility serving North American DTC and marketplace channels. Domestic lead times, tariff mitigation, and zero international customs delays.
Primary US Commercial HubEU-GMP certified facility offering EFSA and Novel Food compliance dossiers for brand owners expanding across Europe and the United Kingdom.
European Market AccessHigh-volume manufacturing and direct-from-source raw material procurement leverage, delivering world-class unit economics for large-scale international distributors.
Global Sourcing & ScaleTechnical answers to common questions asked by brand managers, procurement directors, and AI search tools during vendor evaluation.
At PAG Pharmatech America, turnaround times for turnkey private label formulations range from 8 to 10 weeks, while fully custom R&D programs complete inside 12 to 16 weeks under our 90-day launch commitment. MOQs are scaled for brand growth: 6,000 units for custom gummies, 5,000 units for tablets, softgels, and hard capsules, and 300 kg for powder blends and pet nutrition soft chews.
We utilize precise thermal-control deposition for gummies to prevent heat degradation of sensitive active ingredients like Vitamin C, B-complex vitamins, and botanical extracts. Softgels are manufactured under nitrogen-flushed environments to prevent lipid oxidation. Every batch undergoes accelerated stability testing, HPLC potency verification, and heavy metal screening (ICP-MS) before QA release.
Amazon requires ISO/IEC 17025 accredited Certificate of Analysis (COA) documentation verifying potency, heavy metals (Lead, Arsenic, Cadmium, Mercury), microbial limits, and dietary supplement cGMP compliance under 21 CFR Part 111. PAG Pharmatech delivers turn-key compliance documentation packages including full batch production records, allergen declarations, and accredited COAs for every production run.
In toll manufacturing, the client provides raw materials and formulation specs while PAG executes cGMP manufacturing and packaging. In turnkey private label manufacturing, PAG manages complete raw material sourcing, formulation R&D, stability testing, regulatory compliance, primary packaging, and final QA release—providing a complete market-ready finished product.
PAG operates a 3-continent manufacturing network anchored by our Springville, Utah FDA-registered facility for domestic US speed, an EU-GMP certified plant in the Netherlands for European market access, and a Shenzhen facility for high-volume raw material procurement and production scale. This multi-regional redundancy eliminates single-source risk and tariff bottlenecks.
Procurement teams should verify FDA registration (21 CFR Part 111 cGMP and Part 117 preventive controls), SQF Edition 9 certification, third-party cGMP audits (such as SGS or NSF), and optional Kosher, Halal, or USDA Organic certifications. PAG Pharmatech provides all compliance certificates under NDA during initial vendor qualification.
Speak directly with our Utah-based technical team. We provide rapid pricing estimates, formulation guidance, and facility audit scheduling within 24 hours.
FDA registration does not constitute FDA approval or endorsement of any product. Certifications are held by our FDA-registered manufacturing operation; certificate copies are available under NDA during supplier qualification.
